The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials

Home > Science Hub > The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials
Back to the list

September 27, 2022

Eustache Paramithiotis et al. Frontiers in Immunology 2022

The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials

COVIDpaper

Download publication

You might also be interested by

Posters

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

March 3, 2026

More info

Posters

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

March 3, 2026

More info

Posters

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

March 3, 2026

More info

Web News

CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI

March 3, 2026

More info